The $4,500 injection to stop heroin overdoses

Washington Post, January 27, 2017
by Shefali Luthra, quoting W. Nicholson Price II (Academic Fellow Alumnus)

From the article

:

Thanks to an infusion of public funding to combat opioid overdoses, other institu...

Read More

Promoting healthcare innovation on the demand side

Journal of Law and the Biosciences, January 16, 2017 (online first)
by W. Nicholson Price II (Academic Fellow Alumnus) and Rebecca S. Eisenberg

Abstract: Innovation policy often focuses on fortifying the incentives of firms that develop and sel...

Read More

5 reasons why no one has built a better EpiPen

STAT, September 9, 2016
by Meghana Keshavan, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] But critics say Mylan has little incentive to improve EpiPens: “If you’re the...

Read More

How Mylan cornered the consumer epinephrine market

MedCityNews, September 8, 2016
by Pauline Bartolone, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] The New York state attorney general’s office announced Tuesday it will investigate...

Read More

Euro Drug Pricing’s Tradeoffs May Limit Appeal In US

Law360, September 8, 2016
by Dani Kass, quoting W. Nicholson Price II (Academic Fellow Alumnus)

[...] Going forward, an influx of bills targeting drug prices could be introduced, but few are...

Read More

EpiPen’s Dominance Driven By Competitors’ Stumbles And Tragic Deaths

NPR, September 7, 2016
by Pauline Bartolone, quoting W. Nicholson Price II (Academic Fellow alumnus)

NPR recently called on Petrie-Flom Academic Fellow alumnus Nicholson Price to help explain how...

Read More

US personalized-medicine industry takes hit from Supreme Court

Nature News, August 17, 2016
by Heidi Ledford, quoting W. Nicholson Price II (Academic Fellow alumnus)

From the article

:

Rejections for US patents related to personalized medicine have spiked after rece...

Read More

Promoting Healthcare Innovation on the Demand Side

U of Michigan Law & Econ Research Paper No. 16-008; U of Michigan Public Law Research Paper No. 503
by Rebecca Eisenberg and W. Nicholson Price II (Academic Fellow Alumnus)

Abstract

:

Innovation policy often focuses on the incentives of firms that sell new products. But op...

Read More

Petrie-Flom, 10 years on:

Harvard Law Today, April 14, 2016

On March 29, current and former affiliates of the Petrie-Flom Center for Health Law Policy, Biotechn...

Read More

Big Data, Patents, and the Future of Medicine

Cardozo Law Review, Forthcoming , September 13, 2015
by W. Nicholson Price II (Academic Fellow Alumnus)

>Abstract: 

;

Big data has tremendous potential to improve health care. Unfortunately, intellectu...

Read More

Congress seeks to quash patent trolls

Nature News, May 20, 2015
by Heidi Ledford, quoting W. Nicholson Price II (Academic Fellow Alumnus)

From the article

:

Predatory ‘patent trolls’ could soon find it harder to operate in the...

Read More

Are trade secrets delaying biosimilars?

Science, April 10, 2015
by W. Nicholson Price II (Academic Fellow Alumnus) and Arti K. Rai

Petrie-Flom Academic Fellow alumnus Nicholson Price, now an Assistant Professor at the Uni...

Read More

​Nudging the FDA

The American Interest, October 17, 2014
by W. Nicholson Price II (Academic Fellow alumnus) and I. Glenn Cohen (Faculty Director)

From the article

:

[...] The FDA’s regulation of drugs is frequently the subject of polic...

Read More

How patent reform’s fraught politics have left USPTO still without a boss

The Washington Post, July 30, 2014
by Nancy Scola, quoting W. Nicholson Price II (Affiliated Faculty)

From the article

:

[...] The controversy began in late June when rumors started to trickle out that...

Read More

Pharma manufacturing woes dog industry

Chemistry World, October 23, 2013
by Sarah Moulton, quoting W. Nicholson Price II

[...] While many of these problems arise from quality control failures, according to Nicholson...

Read More

Praise for “Making Do in Making Drugs” by W. Nicholson Price II

Written Description: Patent & IP Blog, Reviewing Recent Scholarship on Patent Law, IP Theory, and Innovation, September 28, 2013
by Camilla Alexandra Hrdy

"'M&M chocolate candies are made with a precision far beyond the capabilities of many drug m...

Read More

Making Do in Making Drugs

Boston College Law Review, forthcoming
by W. Nicholson Price II

>Abstract:  

;

Drug recalls, contamination events, and shortages are on the rise, but drug compan...

Read More

The Food and Drug Administration in the 21st Century: The 2013 Petrie-Flom Center Annual Conference

Friday, May 03, 2013 - May 4, 2013
Conferences
2012-2013
Wasserstein Hall, Milstein East ABC, Harvard Law School
Watch Event Recordings

Conference Descriptio

n

The Food and Drug Administration, the US government’s oldest comprehen...

Read More